NASDAQ:TGTX

Tg Therapeutics Stock Predictions

etoro logo Buy TGTX
*Your capital is at risk
$40.11
+3.47 (+9.47%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

TGTX Prediction Chart

TGTX Predictions History

Latest community submissions for TGTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 23, 2023 $10.09 -4.39% $10.53 V 95.79% 1
Aug 23, 2023 $10.84 +2.74% $10.53 X 97.06% 0
JS JS Pro
Aug 21, 2023 Bullish $10.37 V 1
Aug 21, 2023 $10.86 +4.91% $10.37 V 95.29% 1
Aug 21, 2023 $10.67 +3.07% $10.37 V 97.13% 1
Aug 21, 2023 Bullish $10.37 V 1
Aug 18, 2023 $10.92 +5.13% $10.35 X 94.46% 0
Aug 18, 2023 $10.06 -3.21% $10.35 V 97.17% 1
Aug 18, 2023 Bullish $10.35 X 0
Aug 16, 2023 $10.96 -4.93% $10.75 V 98.04% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for TGTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT TG THERAPEUTICS
TG Therapeutics
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbra...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE